Statutory roles of pharmacists: An international comparative legal analysis of the United States, United Kingdom, and Japan.
TL;DR
Although the United States, the United Kingdom, and Japan share a common trajectory toward expanded pharmacist roles, this evolution is shaped by distinct legal and regulatory architectures, highlighting that legislative structure plays a central role in shaping the development of pharmacy practice and may inform future pharmacist legislation in other jurisdictions.
Abstract
Background
Pharmacists' roles have expanded globally from traditional dispensing toward clinical, preventive, and public health services. However, limited attention has been given to how statutory and regulatory frameworks shape these roles across jurisdictions.
Objectives
This study systematically compares the statutory and regulatory frameworks governing pharmacists and pharmacy practice in the United States, the United Kingdom, and Japan, including a synthesis of pharmacy practice statutes across all 50 U.S. states.
Method
A comparative legal analysis was conducted using statutory and regulatory documents retrieved from official government sources. Regulatory governance, statutory definitions of pharmacists and pharmacy practice, and scope-of-practice authorization were systematically examined. U.S. state statutes were systematically coded using a standardized classification framework to enable cross-state comparison, and findings were synthesized using comparative thematic analysis.
Results
All three jurisdictions demonstrate a broad expansion of pharmacy practice beyond medication dispensing toward patient-centered and public health-oriented services with significant difference in legislative architecture. The United States adopts a decentralized, state-level statutory model with incremental scope expansion. The United Kingdom employs a nationally unified regulatory framework integrated with primary care service commissioning. Japan relies on a centralized statutory system supplemented by policy-driven implementation. Across U.S. states, foundational pharmacy functions are universally defined, while clinical services such as immunization and collaborative practice are widely adopted, whereas independent prescribing, physical assessment, and public health functions remain more limited.
Conclusion
Although the United States, the United Kingdom, and Japan share a common trajectory toward expanded pharmacist roles, this evolution is shaped by distinct legal and regulatory architectures. The findings highlight that legislative structure, rather than professional activity alone, plays a central role in shaping the development of pharmacy practice and may inform future pharmacist legislation in other jurisdictions.